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Abstract
Background: It has recently been suggested that serum procalcitonin (PCT) is of value in the diagnosis of neonatal sepsis, with
varying results. The aim of this prospective multicenter study was to assess the usefulness of PCT as a marker of neonatal sepsis
of nosocomial origin.
Methods: One hundred infants aged between 4 and 28 days of life admitted to the Neonatology Services of 13 acute-care
teaching hospitals in Spain over 1-year with clinical suspicion of neonatal sepsis of nosocomial origin were included in the study.
Serum PCT concentrations were determined by a specific immunoluminometric assay. The reliability of PCT for the diagnosis
of nosocomial neonatal sepsis at the time of suspicion of infection and at 12–24 h and 36–48 h after the onset of symptoms was
calculated by receiver-operating characteristics (ROC) curves. The Youden's index (sensitivity + specificity - 1) was used for
determination of optimal cutoff values of the diagnostic tests in the different postnatal periods. Sensitivity, specificity, and the
likelihood ratio of a positive and negative result with the 95% confidence interval (CI) were calculated.
Results: The diagnosis of nosocomial sepsis was confirmed in 61 neonates. Serum PCT concentrations were significantly higher
at initial suspicion and at 12–24 h and 36–48 h after the onset of symptoms in neonates with confirmed sepsis than in neonates
with clinically suspected but not confirmed sepsis. Optimal PCT thresholds according to ROC curves were 0.59 ng/mL at the
time of suspicion of sepsis (sensitivity 81.4%, specificity 80.6%); 1.34 ng/mL within 12–24 h of birth (sensitivity 73.7%, specificity
80.6%), and 0.69 ng/mL within 36–48 h of birth (sensitivity 86.5%, specificity 72.7%).
Conclusion: Serum PCT concentrations showed a moderate diagnostic reliability for the detection of nosocomial neonatal
sepsis from the time of suspicion of infection. PCT is not sufficiently reliable to be the sole marker of sepsis, but would be useful
as part of a full sepsis evaluation.
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Background
Infections of nosocomial origin are one of the most seri-
ous problems in modern neonatal units. Nursery-
acquired infections are associated with increased mortal-
ity rates, prolonged duration of hospitalization in survi-
vors, and high patient care expenditures. Because very low
birth weight (VLBW) infants in neonatal intensive care
units are at high risk for nursery-acquired infections, the
frequency of these infections has increased in recent dec-
ades as a result of increased survival of immature neonates
[1]. In a previous study of 30,993 admissions to neonatal
units of 27 acute-care hospitals in Spain, the nosocomial
sepsis rate was 2.1% with an incidence density of 0.89 per
1000 patient days. Sepsis rate was 15.6% among VLBW
infants and 1.16% among those weighing ≥ 1500 g [2].
The prevention and control of these infections are thus
major challenges for neonatal intensive care units
(NICUs). Rapid diagnosis, however, is problematic
because the earliest signs of nosocomial infection may be
minimal and are similar to those of various noninfectious
conditions. Bacterial cultures are time-consuming and
other laboratory tests are either not available for routine
use or lack sensitivity or specificity. In this situation,
neonates with risk factors for infection or clinical suspi-
cion of infection are empirically treated with antibiotics.
On the other hand, the presence of multiresistant nursery
flora complicates the choice of antimicrobials. To avoid
unnecessary treatment of noninfected neonates, an early,
sensitive and specific laboratory test would be helpful to
guide clinicians in neonatal units in deciding whether or
not to start antibiotics. Over the past few decades, several
markers of neonatal infection especially leukocyte indexes
and acute-phase reactants, some of which are commonly
used in clinical practice, have been studied. However,
there is less information on the value of these markers for
the diagnosis of sepsis of nosocomial origin compared
with neonatal sepsis of vertical transmission, and, to date,
no single laboratory test has provided rapid and reliable
identification of early infected neonates. This inability has
led to search for new diagnostic markers [3,4].
It has been recently reported that procalcitonin (PCT), the
prohormone of calcitonin, increases markedly in septic
conditions [5] and has appeared to be a good predictor of
infection severity. Furthermore, the finding that PCT is
released into the circulation within 3 h after endotoxin
injection, plateaus at 6 h, and remains elevated for 24 h,
makes PCT a promising new agent for early and sensitive
identification of severe infection both in adults and chil-
dren with promising results [6]. The results of recent stud-
ies suggested the usefulness of PCT for early diagnosis of
early-onset [7-19] and late-onset neonatal sepsis [19-23].
This objective of this prospective multicenter study was to
assess the diagnostic usefulness of PCT as a single marker
of neonatal sepsis of nosocomial origin.
Methods
Since 1995 the neonatal services of 28 acute-care teaching
hospitals distributed across 10 Autonomous Communi-
ties in Spain ("Grupo de Hospitales Castrillo") have been
involved in an ongoing prospective surveillance project to
assess the incidence and characteristics of nosocomial
infections in the neonatal period [2,24]. The neonatal
services of 13 hospitals participated in the present study.
Between January 2000 and January 2001 all consecutive
neonates aged between 4 and 28 days of life with clinical
suspicion of sepsis of nosocomial origin were prospec-
tively included in the study if blood samples were availa-
ble for timed PCT measurement according to three
postnatal periods: at the time of appearance of the first
clinical manifestations and within 12–24 h and 36–48 h
after the onset of symptoms, and complete neonatal and
outcome data were collected to classify the infants into
two distinct populations: confirmed sepsis and not con-
firmed sepsis. The study was approved by the Ethics Com-
mittees of the participating hospitals and the parents gave
their informed consent.
Sepsis of nosocomial origin was suspected in the presence
of at least three clinical signs and one risk factor for the
nosocomial origin of the infectious process (as shown in
Table 1), and laboratory signs consistent with infection
(abnormal hematologic values and/or C-reactive protein
> 1.2 mg/dL). Diagnostic of confirmed nosocomial sepsis
was established when blood culture was positive. If the
pathogens isolated in blood culture were traditional path-
ogens of vertical transmission (Streptococcus agalactiae,
Escherichia coli) and there was a positive maternal vaginal
culture with the same pathogen, the episode was consid-
ered of vertical transmission and was excluded from the
study.
Two successive positive blood cultures from peripheral
percutaneous specimens were required for the diagnosis
of coagulase-negative staphylococci (CoNS) infection [2].
Only one peripheral blood culture was considered valid
when both bottles of the blood culture set grew isolates of
CoNS organisms with identical antibiotic susceptibility
patterns. In patients with a central line, criteria for CoNS
infection included recovery of the same CoNS with iden-
tical antibiotic susceptibility patterns from the peripheral
blood culture and culture of the catheter tip using the
semi-quantitative method of Maki et al. [25]. Because
quantitative cultures without removal of the catheter was
not a routine microbiologic method in all participating
hospitals, the increased bacterial colony counts from
blood drawn through the suspected infected device com-BMC Pediatrics 2006, 6:16 http://www.biomedcentral.com/1471-2431/6/16
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pared to blood from a peripheral venipuncture was not
required for diagnosis. For all blood cultures it was recom-
mended to submit an amount of ≥ 1 mL to the laboratory.
PCT assay
Blood samples were centrifuged within 30 min of collec-
tion. Serum was stored at -20°C before analysis. PCT was
measured in duplicate by a specific immunoluminometric
assay (LUMItest®, Brahms Diagnostica GmbH, Berlin,
Germany), requiring 20 μL of serum and 2 h to complete.
The limit of detection of this immunoluminometric assay
is 0.08 ng/mL. Luminescence was measured automatically
on a Lumat LB 9507 tube luminometer (Berthold Tech-
nologies GmbH & Co. KG, Bad Wildbad, Germany). All
PCT assays were performed by two centralized clinical
chemistry laboratories of two participating hospitals.
Statistical analysis
Statistical analysis was done with the Statistical Package
for the Social Sciences (SPSS) version 11.0 (SPSS Inc., Chi-
cago, Ill, USA) and EPIDAT version 3.0 (Epidemiological
Analysis of Tabulated Data developed by Servicio de
Información sobre Saúde Pública de la Consellería de
Sanidade de la Xunta de Galicia, Spain, and theHealth Sit-
uation Analysis Program of the Pan American Health
Organization, Washington D.C., USA). PCT values are
expressed as median and interquartile (25th–75th) range.
Neither PCT values nor their log transformation were nor-
mally distributed, thus non-parametric tests were used for
analysis. Comparison between groups was made with the
Mann-Whitney U test. The reliability of serum PCT con-
centration for the diagnosis of neonatal sepsis of nosoco-
mial origin was calculated by receiver-operating
characteristics (ROC) curves. The Youden's index (sensi-
tivity + specificity - 1) was used for determination of opti-
mal cutoff values of the diagnostic tests in the different
postnatal periods. Sensitivity, specificity, and the likeli-
hood ratio of a positive and negative result with the 95%
confidence interval (CI) were calculated. Statistical signif-
icance was set at P < 0.05.
Table 1: Clinical signs of neonatal sepsis and risk factors for nosocomial transmission
Clinical signs Data
Respiratory Tachypnea (> 70 breaths/min in preterm babies, > 60 breaths/min in neonates at term)
Subcostal and/or intercostal retractions
Grunting
Apnea > 10 seconds
Hemodynamic Cyanosis
Pallor
Hypotension (blood pressure < 2 SD of the mean for age and weight)
Tachycardia (> 180 beats/min)
Bradycardia (< 100 beats/min in preterm babies, < 80 beats/min in neonates at term)
Poor peripheral perfusion
Digestive Rejection of food
Vomiting
Abdominal distention
Hepatomegaly
Hematologic Anemia (hemoglobin < 10 g/dL in preterm babies, < 11 g/dL in neonates at term)
Jaundice (yellowish staining)
Petechiae
Echymoses
Risk factors for infection Endotracheal intubation
Central venous catheter
Parenteral nutrition
Nasogastric tube
Urinary catheter
Use of methylxantines
Postnatal use of corticosteroids
Ventriculoperitoneal shunt catheter
Artificial feeding
Previous surgical operationBMC Pediatrics 2006, 6:16 http://www.biomedcentral.com/1471-2431/6/16
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Results
A total of 100 neonates (57 males, 43 females) with clin-
ically suspected nosocomial sepsis and a median (inter-
quartile range) age of 13.6 (10.0–24.8) days were
included in the study. The median (interquartile range)
weight at birth was 1270 (950–1990) g and the gesta-
tional age 29.5 (27–34) weeks. Nosocomial neonatal sep-
sis was confirmed in 61 infants. Causative pathogens were
as follows: coagulase-negative Staphylococcus  in 22
patients, Klebsiella pneumoniae in 14, Escherichia coli in 7,
Enterobacter cloacae in 6, Enterococcus in 5, Candida spp. in
2, Pseudomonas aeruginosa in 2, Klebsiella oxytoca in 1, Sta-
phylococcus aureus in 1, and mixed infection by K. pneumo-
niae  and  Enterococcus  in 1. Not confirmed nosocomial
sepsis group included 7 patients with only one blood cul-
ture positive to CoNS that did not me meet the rest of our
criteria for confirmed nosocomial sepsis.
As shown in Table 2, serum concentrations of PCT were
significantly higher at initial suspicion and at 12–24 h and
36–48 h after the onset of symptoms in neonates with cul-
ture-proven sepsis than in neonates with clinically sus-
pected but not confirmed sepsis. In the group of 61
infants with confirmed nosocomial sepsis, serum PCT
concentrations were significantly lower in the group of 22
patients with infections caused by CoNS than in the
remaining 39 patients with infections of other etiologies
(Table 2, Figure 1).
ROC curves comparing PCT values for diagnosis of neona-
tal sepsis of nosocomial origin at the time of clinical sus-
picion and 12–24 h and 36–48 h after the onset of
symptoms are depicted in Figure 2. The areas under the
ROC curve for the three periods were 0.783 (95% CI,
0.675 to 0.892), 0.805 (95% CI, 0.707 to 0.903), and
0.802 (95% CI, 0.699 to 0.905), respectively. Statistically
significant differences in the areas under the ROC curves
were not found. Cutoff levels with the optimum diagnos-
tic efficiency derived from the ROC curves were ≥ 0.59 ng/
mL at the time of clinical suspicion (sensitivity 81.4%,
specificity 80.6%); ≥ 1.34 ng/mL at 12–24 h after the
onset of symptoms (sensitivity 73.7%, specificity 80.6%);
and ≥ 0.69 ng/mL at 36–48 h after the onset of symptoms
(sensitivity 86.5%, specificity 72.7%) (Table 3).
Discussion
Sepsis of vertical transmission in the newborn infant has
been a nearly constant concern in Neonatology, but devel-
opment of nosocomial infections from acquisition of bac-
terial and other microbial pathogens in the nursery has
become a challenging complication as a result of
increased survival of VLBW infants or premature infants
affected with severe diseases. However, there are relatively
few studies of the value of serum PCT for the diagnosis of
nosocomial neonatal sepsis, and none of them is a multi-
center one. Monneret et al. [19] assessed daily variations
in serum PCT in comparison with C-reactive protein
(CRP) in 94 control and infected newborn infants, with
14 infected infants and 17 controls between the 4 and 28
days of life. Although in this study, procalcitonin seems to
be an interesting marker of neonatal sepsis (early PCT
peak compared with CRP), data to estimate diagnostic
reliability are lacking. Chiesa and associates [9,21]
reported the results of a study that included 23 cases of
nosocomial infection and 92 asymptomatic controls
between 3 and 30 days of life, in which serum PCT con-
centration discriminated all cases of sepsis with a 100%
sensitivity and specificity. All infected infants had PCT val-
ues of ≥ 2 ng/mL and all controls ≤ 1 ng/mL. Enguix et al.
[20] evaluated serum PCT as a diagnostic marker of bacte-
rial sepsis in newborns aged 3–30 days admitted to the
NICU (20 neonates with sepsis, 26 neonates without sep-
sis), and found a sensitivity of 98.6% and specificity of
88.9% for an optimum diagnostic cutoff value of ≥ 8.05
ng/mL, without statistically significant differences in com-
parison with CRP and serum amyloid. Kawczynski et al.
[22] evaluated PCT and CRP in 48 newborn infants who
suffered from nosocomial sepsis, reporting sensitivity of
89.6% for PCT and 66.7% for RCP at the onset of sepsis,
that improved to 100% and 89.6% respectively 24 hours
Table 2: Differences in serum PCT values according to final diagnosis (confirmed vs. not confirmed) and etiology (coagulase-negative 
staphylococci vs. other pathogens) of sepsis
Study group Serum PCT values, ng/mL median (25th–75th interquartile range)
Onset of symptoms 12–24 h 36–48 h
Not confirmed sepsis, n = 39 0.34 (0.24–0.58) 0.44 (0.25–1.20) 0.47 (0.33–0.92)
Confirmed sepsis, n = 61 2.46 (0.68–23.20) 12.65 (1.01–49.00) 5.15 (0.99–16.23)
P value* < 0.0001 < 0.0001 < 0.0001
Sepsis caused by CoNS, n = 22 0.76 (0.42–7.70) 1.48 (0.56–16.44) 0.88 (0.51–2.27)
Sepsis caused by other pathogens, n = 39 7.60 (1.01–27.01) 20.85 (6.54–63.50) 8.62 (4.32–32.0)
P value* < 0.049 < 0.003 < 0.0003
*Mann-Whitney U test.BMC Pediatrics 2006, 6:16 http://www.biomedcentral.com/1471-2431/6/16
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later. Unfortunately, only septic newborns where
included, so it was no possible to calculate specificity.
More recently, Vazzalwar et al [23] assessed PCT for the
diagnosis of late-onset sepsis in 67 very low birth weight
infants. At a PCT cutoff value of 1.0 ng/mL sensitivity was
97% and specificity 80%, while with CRP sensitivity was
72% and specificity 93%.
In the present study, the diagnostic reliability of serum
PCT was modest, with sensitivities and specificities
slightly higher than 80% at the time of suspicion of noso-
comial infection. It should be noted that in the studies of
Enguix et al. [20] and Chiesa et al. [21], a control group
formed by asymptomatic infants without evidence of
infection or with a diagnosis on admission easily differen-
tiable from nosocomial sepsis was included, which may
overestimate the reliability of a diagnostic test [26]. We
studied a homogeneous group of neonates with clinically
suspected nosocomial sepsis in which pre-established cri-
teria for the definitive diagnosis of sepsis were applied, an
approach that closely resembles the clinical scenario
where the diagnostic test is intended to be used. On the
other hand, because of the requirement of strict microbio-
logic criteria for the final diagnosis of sepsis, it may be
possible that some cases of true bloodstream infection
could not have been confirmed due to false negative
blood cultures.
The use of PCT for the diagnosis of sepsis of vertical trans-
mission is influenced by the physiologic peak of this
marker during the first 48 h of life [9,27], but this phe-
nomenon is obviated because nosocomial sepsis develops
on a later time. It has been reported that elevations of PCT
in neonates infected with CoNS are lower than serum PCT
increases in sepsis caused by other pathogens [21]. In our
study, serum PCT concentrations were significantly lower
in the group of 22 patients with infections caused by
CoNS than in the remaining 39 patients with infections of
other etiologies. This is a relevant finding given the high
frequency of infections caused by CoNS in the NICU.
Diagnostic reliability of serum PCT was not compared
with CRP or other infection markers, such as leukocyte
count, given that these laboratory tests were not standard-
ized and were performed according to techniques of each
participating hospital, and they were used to define sepsis.
Although this may be considered a limitation of the
present findings, the study was to assess the diagnostic
usefulness of PCT as a single marker of neonatal sepsis of
nosocomial origin. In addition, a comparative study
would have required a bigger sample size in order to
detect differences between infection markers.
Studies about diagnostic tests should be carried out in a
patient sample that includes an appropriate spectrum of
patients to whom the diagnostic test will be applied in
clinical practice, and compared with a sufficiently reliable
Table 3: Diagnostic accuracy of serum PCT for the diagnosis of neonatal sepsis of nosocomial origin
Data Onset of symptoms 12–24 h 36–48 h
Cutoff value, ng/mL 0.59 1.34 0.69
Sensitivity, % (95% CI) 81.4 (69.6–89.3) 73.7 (61.0–83.4) 86.5 (74.7–93.3)
Specificity, % (95% CI) 80.6 (65.0–90.2) 80.6 (65.0–90.2) 72.7 (55.8–84.9)
Positive predictive value, % (95% CI) 87.3 (76.0–93.7) 85.7 (73.3–92.9) 83.3 (71.3–91.0)
Negative predictive value, % (95% CI) 72.5 (57.2–83.9) 65.9 (51.1–78.1) 77.4 (60.2–88.6)
Youden's index 0.62 0.54 0.59
Likelihood ratio of a positive result (95% CI) 4.18 (2.13–8.23) 3.79 (1.91–7.50) 3.17 (1.80–5.60)
Likelihood ratio of a negative result (95% CI) 0.23 (0.13–0.40) 0.33 (0.21–0.52) 0.19 (0.09–0.38)
PCT in sepsis caused by CoNS versus other pathogens Figure 1
PCT in sepsis caused by CoNS versus other patho-
gens. Box plot comparing PCT concentrations in neonates 
with nosocomial sepsis caused by coagulase-negative Staphy-
lococcus versus other causative pathogens.
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"gold standard" [26]. Unfortunately, an ideal "gold stand-
ard" for the definition of neonatal sepsis is not available
and, for this reason, different definitions according to
clinical, microbiologic, or laboratory criteria are used.
Recently, the international pediatric sepsis consensus con-
ference [28] modified the adult systemic inflammatory
response syndrome (SIRS) criteria for children, incorpo-
rating pediatric physiologic variables for the subcategories
of newborn, neonate, infant, child, and adolescent. How-
ever, premature infants were not included in the new-
borns group. Therefore, from the NICUs perspective,
reference values of heart rate, respiratory rate, leukocyte
count, and systolic blood pressure included in the defini-
tion of SIRS should be conveniently updated, as well as
evidences (clinical, microbiologic, laboratory, radiologic)
required to consider infection as the cause of SIRS. On the
other hand, little guideline or consensus exists in litera-
ture for the differentiation between neonatal sepsis of ver-
tical transmission and nosocomial sepsis, usually defined
as early-onset and late-onset sepsis. The chronologic crite-
ria, however, is inadequate for cases of early-onset noso-
comial sepsis or late-onset bloodstream infection of
vertical transmission that have a different profile of caus-
ative organisms and distinct therapeutic approach. An
international consensus definition of these relevant
aspects of pediatric sepsis will facilitate the performance
of clinical studies in neonates with sepsis and the applica-
tion of the results obtained in the daily practice.
Conclusion
In this prospective multicenter study of 61 neonates with
a definitive diagnosis of nosocomial sepsis, serum PCT
concentrations showed a moderate diagnostic reliability
for the detection of neonatal sepsis of nosocomial origin
from the time of suspicion of infection. PCT is not suffi-
ciently reliable to be the sole marker of sepsis, but would
be useful as part of a full sepsis evaluation. Comparative
studies with other markers of infection are needed as well
as an adequate consensus definition of nosocomial neo-
natal sepsis to determine the real value of PCT in daily
practice.
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